Kerstin Albus Selected Research

Kerstin Albus Research Topics

5	Neoplasms (Cancer) 10/2016 - 11/2012
4	Lung Neoplasms (Lung Cancer) 11/2015 - 11/2012
3	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2022
2	Obesity 01/2023 - 01/2023
1	Pneumonia (Pneumonitis) 07/2023
1	Body Weight (Weight, Body) 01/2023
1	Weight Gain 01/2023
1	Hyperphagia (Overeating) 01/2023
1	COVID-19 01/2022
1	Insulin Resistance 01/2021
1	Infections 01/2021
1	Adenocarcinoma of Lung 10/2016
1	Small Cell Carcinoma 02/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2011
1	Autoimmune Diseases (Autoimmune Disease) 09/2008

3	VaccinesIBA 01/2023 - 01/2022
2	Insulin (Novolin)FDA Link 01/2021 - 05/2011
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 02/2014 - 11/2012
1	Liraglutide FDA Link 01/2023
1	SugarsIBA 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	Dopamine (Intropin)FDA LinkGeneric 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	rociletinibIBA 10/2016
1	osimertinibIBA 10/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2015
1	Phosphotransferases (Kinase)IBA 11/2015
1	DNA (Deoxyribonucleic Acid)IBA 07/2015
1	LigandsIBA 02/2014
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2014
1	InsulinsIBA 05/2011
1	Short-Acting InsulinIBA 05/2011
1	Insulin Lispro (Humalog)FDA Link 05/2011
1	Complement Receptors (Complement Receptor)IBA 09/2008

5	Therapeutics 10/2016 - 11/2012
1	Renal Dialysis (Hemodialysis) 07/2023
1	Critical Care (Surgical Intensive Care) 01/2021
1	Aftercare (After-Treatment) 10/2016
1	Genomic Medicine 07/2015